<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2633">We included RCTs that evaluated clinical outcomes associated with intravenous selenium as single or combined strategy in parenterally or enterally fed patients. Overall mortality was the primary outcome; secondary outcomes were infections, ICU length of stay (LOS), hospital LOS, and ventilator days. Subgroup analyses were done to elucidate the effects of selenium on mortality and infections (TableÂ 
 <xref rid="Tab41" ref-type="table">41</xref>).
</p>
